106.961 articles found

Psychotic complications of long term levodopa treatment of Parkinson's disease.

Rampello L, Raffaele R, Furnari P, Vecchio I, Malaguarnera M.

Arch Gerontol Geriatr · 1996-01-01

DOI: 10.1016/0167-4943(96)86915-9PMID: 18653010

Event related potentials and serial list picture memory in Parkinson's patients.

Korsnes MS, Reinvang I.

Behav Neurol · 1996-01-01

DOI: 10.3233/ben-1996-9203PMID: 24487490

Procedural memory: computer learning in control subjects and in Parkinson's disease patients.

Thomas-Antérion C, Laurent B, Foyatier-Michel N, Laporte S, Michel D.

Behav Neurol · 1996-01-01

DOI: 10.3233/ben-1996-93-404PMID: 24487512

Somatosensory evoked potentials and dopaminergic responsiveness to apomorphine and levodopa in parkinsonian patients.

Miranda M, Castillo JL, Araya F.

Behav Neurol · 1996-01-01

DOI: 10.3233/ben-1996-93-406PMID: 24487514

SYSTEM AND METHOD FOR DETECTION AND QUANTIFICATION OF PARKINSON'S DISEASE

HOCHERMAN Shraga.

· 1995-12-29

1-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF.

Kotake Y, Tasaki Y, Makino Y, Ohta S, Hirobe M.

J Neurochem · 1995-12-01

DOI: 10.1046/j.1471-4159.1995.65062633.xPMID: 7595560

Absence of mutations in superoxide dismutase and catalase genes in patients with Parkinson's disease.

Parboosingh JS, Rousseau M, Rogan F, Amit Z, Chertkow H, Johnson WG, Manganaro F, Schipper HN, Curran TJ, Stoessl J.

Arch Neurol · 1995-12-01

DOI: 10.1001/archneur.1995.00540360038013PMID: 7492289

Neuropsychological impairment in Parkinson's disease with and without depression.

Tröster AI, Stalp LD, Paolo AM, Fields JA, Koller WC.

Arch Neurol · 1995-12-01

DOI: 10.1001/archneur.1995.00540360042014PMID: 7492290

Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.

Antonini A, Vontobel P, Psylla M, Günther I, Maguire PR, Missimer J, Leenders KL.

Arch Neurol · 1995-12-01

DOI: 10.1001/archneur.1995.00540360061017PMID: 7492293

Clinical and [18F] dopa PET findings in early Parkinson's disease.

Morrish PK, Sawle GV, Brooks DJ.

J Neurol Neurosurg Psychiatry · 1995-12-01

DOI: 10.1136/jnnp.59.6.597PMID: 7500096

Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease.

Levivier M, Przedborski S, Bencsics C, Kang UJ.

J Neurosci · 1995-12-01

DOI: 10.1523/jneurosci.15-12-07810.1995PMID: 8613721

Risk of dementia in patients with Parkinson's disease, epilepsy, and severe head trauma: a register-based follow-up study.

Breteler MM, de Groot RR, van Romunde LK, Hofman A.

Am J Epidemiol · 1995-12-01

DOI: 10.1093/oxfordjournals.aje.a117597PMID: 7503050